AIDS

From funding the Human Genome Project to investing in HIV/AIDS treatment to supporting the creation of the COVID-19 vaccines, we’ve proven time and again that strong national governance can overcome scientific obstacles.

Just as success appears within reach to end fatalities from HIV/AIDS worldwide, the U.S. — the global leader in that battle — seems to be in retreat.

In a statement, Caltech President Thomas Rosenbaum said Baltimore’s “contributions as a virologist, discerning fundamental mechanisms and applying those insights to immunology, to cancer, to AIDS, have transformed biology and medicine.”

The state attorneys said their public universities were using grant money for “projects investigating heart disease, HIV/AIDS, Alzheimer’s disease, alcohol and substance abuse, mental-health issues, and countless other health conditions.”

The near-conquest of HIV/AIDS in Zambia is a great story and it’s not the only one.